ISRG Intuitive Surgical Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
10:45
Aug 12
Aug 12
JPMorgan, Deutsche Bank, Mizuho, Oppenheimer, Daiwa, Citizens, BTIG, William Blair, Jefferies.
JPMorgan, Deutsche Bank, Mizuho, Oppenheimer, Daiwa, Citizens, BTIG, William Blair, Jefferies, Berenberg, Raymond James, and China Renaissance issue multiple upgrades and downgrades with price target changes across a broad set of stocks.
22:35
Aug 05
Aug 05
Watch surgical and electrophysiology med-tech names
Watch ISRG, BSX, MDT as lower-confidence TTM read-through beneficiaries from surgical robotics and electrophysiology PCB strength; affected-company map, not author picks.
MED
12:30
Aug 04
Aug 04
EMG's organic orders surged 35% in Q2, partly driven by med-tech design wins in Paragon, implying stronger near-term revenue and margin expansion as those orders convert. — Robust MedTech orders signal health in med-tech capital spending and procedure volumes, benefiting OEM customers like Intuitive Surgical.
MED
10:46
Jul 30
Jul 30
Author added Intuitive Surgical to his watchlist after a 40% decline from its 52-week high, indicating potential value opportunity.
MED
12:11
Jul 28
Jul 28
UBS, Leerink Partners, BofA, JPMorgan, Truist, Exane BNP Paribas.
UBS, Leerink Partners, BofA, JPMorgan, Truist, Exane BNP Paribas, and Wells Fargo issued multiple analyst upgrades and initiations across a range of stocks including Edwards Lifesciences, Enovis, Gossamer Bio, Honeywell, International Paper, Intuitive Surgical, Magnolia Oil & Gas, Nutrien, QXO, and Stryker.
07:18
Jul 25
Jul 25
Intuitive Surgical’s June-quarter earnings grew 24%, but the stock fell 17% because it didn’t raise its already-strong 14% procedure growth guidance. The market punished an absence of guidance boost, not a fundamental deterioration; the company has a history of beating guidance (18% vs 14% last year). The drop is a classic buying opportunity in a monopoly with 20%+ upside expectations from Wall Street. New competition from J&J could eventually dent market share; procedure growth could slow further if utilization worsens.
HIGH
19:04
Jul 17
Jul 17
Intuitive Surgical shares fell despite a Q2 revenue beat due to domestic growth concerns.
Intuitive Surgical shares fell despite a Q2 revenue beat due to domestic growth concerns and a Stifel price target cut, with the Seeking Alpha Quant score at neutral HOLD.
12:34
Jul 17
Jul 17
US pre-market movers show broad declines led by semiconductor and tech ETFs on competitive.
US pre-market movers show broad declines led by semiconductor and tech ETFs on competitive pressure from Moonshot AI, while Alcoa, SpaceX, Intuitive Surgical, Autoliv, and SouthFirst Bancshares all fell on earnings or operational misses.
12:16
Jul 17
Jul 17
Premarket movers show Mag 7 stocks and chipmakers all lower amid a broad tech selloff.
Premarket movers show Mag 7 stocks and chipmakers all lower amid a broad tech selloff, with Autoliv, Intuitive Surgical, Netflix, and Staar Surgical all falling on earnings-related news.
01:55
Jul 17
Jul 17
Intuitive Surgical shares fell as much as 13% in after-market trading after growth in da Vinci.
Intuitive Surgical shares fell as much as 13% in after-market trading after growth in da Vinci robot use slowed to its weakest pace in four years and procedure guidance remained unchanged.
22:41
Jul 16
Jul 16
Intuitive Surgical reported strong Q2 2026 results with revenue up 19 percent to 2.89 billion.
Intuitive Surgical reported strong Q2 2026 results with revenue up 19 percent to 2.89 billion dollars driven by da Vinci 5 and ION adoption.
20:07
Jul 16
Jul 16
Intuitive Surgical reports second-quarter revenue and adjusted earnings above analyst estimates.
Intuitive Surgical reports second-quarter revenue and adjusted earnings above analyst estimates and forecasts full-year da Vinci procedure growth near the midpoint of its guidance range.
11:56
Jul 16
Jul 16
The author provides a comprehensive macro and market brief highlighting geopolitical escalation.
The author provides a comprehensive macro and market brief highlighting geopolitical escalation, consumer deterioration, and technical fragility from gamma expiry and buyback blackout without stating any personal positions or forward calls.
14:00
Jul 14
Jul 14
Healthcare sector rotation for midterms.
Healthcare is set to dramatically outperform. The sector has fallen from 16-17% of the S&P 500 to just 8%, and a rotation is underway as midterm election dynamics favor Democrats and fiscal hawks. The firm has gone long healthcare, highlighting Intuitive Surgical and Baxter.
MED
21:06
Jul 12
Jul 12
The author reflects on past ownership and curiosity about Intuitive Surgical but expresses no.
The author reflects on past ownership and curiosity about Intuitive Surgical but expresses no current position or forward-looking trade idea.
LOW
20:31
Jul 12
Jul 12
The author shares a humorous bracket contest mention and lists their "Callfolio" holdings.
The author shares a humorous bracket contest mention and lists their "Callfolio" holdings as a personal portfolio snapshot without making any forward-looking trade calls or endorsements.
LOW
03:15
Jul 05
Jul 05
Author discloses an active existing long position in Intuitive Surgical (ISRG).
Author discloses an active existing long position in Intuitive Surgical (ISRG), confirming current bullish exposure with no stated exit or concern.
MED
01:21
Jul 03
Jul 03
Author describes a balanced core portfolio rebalanced in June 2026 that has outperformed.
Author describes a balanced core portfolio rebalanced in June 2026 that has outperformed the S&P 500, but the tweet is a retrospective performance update and general advice to stay balanced, not a fresh trade call.
15:54
Jul 02
Jul 02
Long these names as part of a balanced portfolio rebalanced on 6/15 to rotate out of tech into.
Long these names as part of a balanced portfolio rebalanced on 6/15 to rotate out of tech into healthcare, financials, energy, and defensives, outperforming SPY by 4x.
MED
13:45
Jun 29
Jun 29
Author identifies Physical AI and Robotics as a potential supercycle and lists these companies.
Author identifies Physical AI and Robotics as a potential supercycle and lists these companies as watchlist candidates; no directional commitment.
LOW
20:40
Jun 23
Jun 23
The author is researching the Physical AI value chain and asking for additions to their.
The author is researching the Physical AI value chain and asking for additions to their overview, not expressing any directional positions.
LOW
19:53
Jun 11
Jun 11
Intuitive Surgical data AI advantage buy.
Intuitive Surgical (ISRG) sits on an incredibly valuable proprietary dataset from robotic-assisted surgeries worldwide, positioning it as an AI-driven profit beast over the next 5-10 years. The stock is unloved, underowned, and currently near its 200-day moving average, presenting a screaming buy opportunity.
HIGH
17:29
Jun 11
Jun 11
Intuitive Surgical AI data play, buy
Intuitive Surgical possesses the best proprietary surgical data, positioning it as a future AI profit beast analogous to Tesla's data advantage in autonomous driving. The stock is unloved, underowned, and trading on its 200-week moving average, presenting a screaming buy.
HIGH
10:50
Jun 08
Jun 08
A community member opened a “big bet” on ISRG after years of following the company, expressing high conviction. ISRG is a dominant player in robotic surgery with a durable moat; current entry offers diversification away from overhyped AI names. The upvoted comment endorses ISRG as a long‑term healthcare leader worth buying on dips. Procedure volume variability, regulatory hurdles, and a rich valuation could cap upside.
LOW
17:18
Jun 05
Jun 05
Author discloses a recent purchase of ISRG made Tuesday, now up 6%; no catalyst given.
Author discloses a recent purchase of ISRG made Tuesday, now up 6%; no catalyst given, minimal conviction signal from a retail holder's recent buy disclosure.
MED
14:13
Jun 03
Jun 03
Buy ISRG as Piper Sandler field checks confirm bear concerns are overblown.
Buy ISRG as Piper Sandler field checks confirm bear concerns are overblown — DV5 driving higher utilization without cannibalizing Xi volumes, ASC expansion and cardiovascular procedures are incremental growth drivers, and the company beat top/bottom line last quarter; shares dropped below $400 despite consensus PTs of $520–$651.
MED
02:10
Jun 03
Jun 03
Long quality compounder names ISRG, LLY, MA on the thesis that as AI stocks price earnings.
Long quality compounder names ISRG, LLY, MA on the thesis that as AI stocks price earnings further out, these high-quality non-AI growers are increasingly attractive on a relative basis and are being ignored by the market.
MED
17:54
Jun 02
Jun 02
Buy quality non-AI compounders as AI stocks price growth further out.
Buy quality non-AI compounders as AI stocks price growth further out, making established growth names like ISRG, LLY, and MA relatively more attractive on a forward-growth-priced-in basis.
MED
16:03
Jun 02
Jun 02
Buy ISRG on price dislocation below $400 despite Piper Sandler's $580 PT.
Buy ISRG on price dislocation below $400 despite Piper Sandler's $580 PT; razor-and-blade recurring revenue model, 11,000 installed systems, 10M+ procedures create durable data moat with AI/robotics tailwinds supporting consistent YoY sales growth.
MED
About ISRG Analyst Coverage
Buzzberg tracks ISRG (Intuitive Surgical Inc.) across 29 sources. 21 bullish vs 0 bearish calls from 30 analysts. Sentiment: predominantly bullish (38%). 55 total trade ideas tracked. Past 7 days: 1 watch. Latest voices: DeItaone, TheValueist, David A. Zapico.